Latest Posts

30

May 24

Partex and Singapore’s Experimental Drug Development Centre collaborate to bring forward an innovative approach for early drug discovery and development

featured, Press release 2024
Frankfurt, Germany, 3rd June 2024, 9am CET Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled...
Read More

22

Apr 24

Partex Partners with Lupin to Revolutionize Drug Discovery through AI-Driven Asset Search and Evaluation

featured, Press release 2024
Frankfurt, Germany, 23 April 2024 – Partex, a leading provider of AI-driven solutions in the pharmaceutical industry, is thrilled to...
Read More

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
Try Ontosight® For Free

Innoplexus Announces New North American Affiliate Helmed by Former Merck KGaA Executive

Leader in Pharmaceutical Research AI expands North American Presence.

HOBOKEN, NJ, May 10, 2018 /24-7PressRelease/ — Innoplexus, a leader in artificial intelligence and data analytics solutions for pharmaceutical and life science research, announced today the opening of Innoplexus Americas. This new affiliate will focus on empowering pharmaceutical companies in the United States and Latin America to achieve new heights of creativity and innovation through augmented data analytics capabilities.

Innoplexus has hired experienced pharmaceutical executive Lawrence Ganti to serve as Innoplexus America’s inaugural CEO. Mr. Ganti comes to Innoplexus with a plethora of leadership experience in the pharmaceutical space. Most recently, he was President of Merck KGaA’s Latin American business. His prior experience includes General Manager roles with Merck in Brasil and India. He was also Head of Commercial Development for Merck’s Emerging Markets Business Unit, where he consolidated the strategy and business analytics functions. Prior to his roles with Merck, Mr. Ganti held positions with McKinsey & Company and various technology starts-ups.

Mr. Ganti’s experience as a global pharmaceutical leader gives him an insider’s perspective on the opportunities and challenges within pharmaceutical innovation. He stated, “Data analytics has become a core competency for Pharma. It’s definitely not something you want to outsource. What brought me to Innoplexus is our approach of empowering pharma with customized ecosystems enhanced with relevant data grounded in the life sciences. Our tools and people speak the language of pharma and apply that to our AI and Machine Learning technologies.”

Featured News

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased to announce a one-of-its-kind collaboration with Anavex Life science corp. for Artificial Intelligence (AI) enabled drug development and healthcare sales marketing
on June 27, 2023

Strategic partnership announcement: Innoplexus holding company Partex NV is pleased

Exciting News! Anavex Life Sciences and Partex NV Announce Strategic Partnership to Enhance Patient Experience. Anavex Life Sciences Corp. and Partex NV N.V. Group are pleased to announce…

Read More